Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

March 31, 2003

Conditions

Sarcoma

Interventions

DRUG

PN-152,243)/PN-196,444

Trial Locations (6)

Pfizer Investigational Site, Radnor

Pfizer Investigational Site, Philadelphia

Pfizer Investigational Site, Park Ridge

Pfizer Investigational Site, Chicago

Pfizer Investigational Site, Houston

Pfizer Investigational Site, Los Angeles